Stop relying on short-term pilot studies or anecdotal evidence to justify your hands. A brand-new, high-level Randomized Clinical Trial (RCT) from Michener et al. (2024), published in JOSPT Open, just delivered the definitive answer we've been waiting for.
This wasn't a quick six-week intervention. This study compared two groups with subacromial shoulder pain:
Exercise-Only (EX): A standardized, well-designed exercise program.
Exercise + Manual Therapy (EX+MT): The exact same exercise program plus targeted spinal and shoulder manual therapy.
And the best part? The researchers followed these patients for a full 52 weeks (one year).
The results are a clear, clinical, and patient-centered win for the integrated approach. At the 6-month and 1-year follow-up, the EX+MT group significantly outperformed the Exercise-Only group across all primary outcome measures.
Superior Function: The EX+MT group had a clinically meaningful 6.7-point advantage on the DASH score at 52 weeks. That’s the difference between a patient still struggling with daily tasks and a patient who is thriving.
Happier Patients: The integrated group reported significantly higher patient satisfaction and a greater percentage of patients reporting a successful outcome (GROC success).
This isn't about a fleeting analgesic effect. This is proof that Manual Therapy facilitates superior, more durable functional change than exercise alone.
If you're still treating with an either/or mentality, you are shortchanging your patient's long-term potential. This study validates the core principle of Modern Manual Therapy: Hands-on care is a neuro-modulator that creates the window of opportunity for effective exercise.
We don't use a Grade IV mobilization to "fix" a supraspinatus tear. We use it to change the immediate sensorimotor output, reduce the threat, and allow the patient to access a higher quality of movement and greater load during the corrective and strengthening exercises that follow.
This is your new clinical playbook. You now have high-level evidence to confidently tell your patients, referral sources, and even skeptical colleagues WHY your combined approach leads to better outcomes and more satisfied patients a year down the road.
Stop debating. Start integrating.
Scroll down for the full infographic breakdown of the Michener 2024 RCT and a clinical playbook on how to implement this multimodal gold standard for shoulder pain starting tomorrow.
A 2024 *JOSPT Open* trial provides powerful, long-term evidence for combining manual therapy with exercise for subacromial pain.
We know exercise is key for subacromial shoulder pain, but guidelines have "low certainty" on adding manual therapy (MT). Does MT provide more than just short-term relief? A 2024 RCT finally gives us a long-term answer.
This RCT compared two groups: an Exercise-Only (EX) program vs. the same Exercise program *plus* Spine and Shoulder Manual Therapy (EX+MT).
✓ SUPERIOR DISABILITY SCORES
The EX+MT group had significantly better DASH scores at both 6 months and 1 year. The 52-week difference was a clinically meaningful 6.7 points.
✓ HIGHER PATIENT SATISFACTION
The EX+MT group reported significantly higher satisfaction with their shoulder at both 6 and 12-month follow-ups.
✓ GREATER PERCEIVED BENEFIT
A higher percentage of patients in the EX+MT group reported a successful outcome (GROC success) at 26 and 52 weeks.
MT isn't just a passive fix. It's a neuro-modulator that changes pain and sensorimotor processing, creating a "window of opportunity" for the patient to exercise more effectively.
This is high-level evidence that an integrated approach is superior for *long-term* function and satisfaction. You can now confidently explain *why* you combine hands-on care with their exercise plan.
Stop the 'either/or' debate. Use your manual skills (including spinal) to facilitate your exercise prescription. This multimodal approach leads to more durable outcomes and happier patients.